The fastest route to launching your pharmaceutical brand
Under Biodeal's loan licensing model, your brand accesses our WHO-GMP certified manufacturing infrastructure, quality systems and drug manufacturing licences — without the capital expenditure of building or leasing a plant.
The most efficient way to bring products to market
Pharmaceutical loan licensing is the most efficient and cost-effective route for marketing companies to launch products. Instead of investing years and crores into a manufacturing plant, your brand operates on top of infrastructure that already exists — fully licensed, audited and running.
That means you focus capital and attention on what actually grows the business: the brand, the portfolio and the market. Biodeal handles the facility, the quality systems and the licences, while the product ships under your name.
No capex
Skip the cost of building or leasing a GMP-certified manufacturing facility.
Your brand
Products are made and packed under your own brand name, ready to sell.
Licences in place
Manufacture on Biodeal's existing drug manufacturing licences from day one.
Four steps to a launched brand
From your first product list to dispatch under your own name — a clean, predictable path with one accountable partner throughout.
Share your brief
Submit your product list, brand details and target markets to Biodeal.
Feasibility review
Biodeal's R&D and regulatory team reviews formulation feasibility and regulatory requirements.
Manufactured for you
Products are manufactured at Biodeal's licensed facility under your brand name.
Dispatched to you
Finished products are dispatched directly to your warehouse, distributor or C&F agent.
Built for everyone who'd rather build a brand than a plant
Loan licensing suits any organisation that wants quality manufacturing without owning the infrastructure behind it.
First-time founders
Pharmaceutical entrepreneurs launching their very first brand, without the capital to build a facility.
Established brands
Existing brands expanding their product portfolio without adding new manufacturing lines.
Regional pharma
Regional companies adding new therapeutic areas to their existing range with minimal risk.
Nutra & herbal brands
Nutraceutical and herbaceutical brands wanting GMP-grade manufacturing under their own label.
International companies
Overseas companies seeking an Indian manufacturing base for domestic market registration.
Loan licensing, answered
The questions brands ask most often before starting a loan licensing arrangement.
What is loan licensing in the pharmaceutical industry?
Loan licensing is an arrangement where a marketing company uses the manufacturing licence and GMP-certified facility of a licensed manufacturer (like Biodeal) to produce and sell pharmaceutical products under their own brand — eliminating the need for capital investment in manufacturing infrastructure.
Who should use Biodeal's loan licensing service?
Pharmaceutical entrepreneurs launching their first brand, established brands expanding their product portfolio, regional pharma companies adding new therapeutic areas, nutraceutical and herbaceutical brands, and international companies seeking an Indian manufacturing base for domestic market registration.
Start loan licensing with Biodeal
Send us your product list, brand details and target markets — our team reviews feasibility and responds with a clear loan licensing pathway and product portfolio.